AAVantgarde Announces FDA Orphan Drug Designation and UK CTA approval for AAVB-039 for the Treatment of Stargardt Disease October 3, 2025
Sitryx receives FDA clearance of IND application for SYX-5219 for the treatment of atopic dermatitis October 2, 2025
James Mackay is tending to ‘unfinished business’ with new gout biotech and $205M fundraise September 30, 2025
Crystalys lands $205M to bring gout drug first marketed in Japan to the US and Europe September 30, 2025
